SFS
XLRN

Sowell Financial Services’s Acceleron Pharma XLRN Stock Holding History

Sowell Financial Services’s Portfolio XLRN Stock Details XLRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-191
Closed -$23K – 3139
2021
Q1 		$23K Sell
191
-30
-14% -$3.88K ﹤0.01% 2015
2020
Q4 		$28K Sell
221
-5
-2% -$586 ﹤0.01% 1610
2020
Q3 		$25K Buy
226
+11
+5% +$1.09K ﹤0.01% 1471
2020
Q2 		$20K Sell
215
-50
-19% -$4.82K ﹤0.01% 1471
2020
Q1 		$24K Sell
265
-1,094
-81% -$85K ﹤0.01% 1337
2019
Q4 		$72K Buy
1,359
+1,130
+493% +$51.5K 0.01% 1013
2019
Q3 		$9K Buy
+229
New +$9.94K ﹤0.01% 1588
2017
Q1 		– Sell
-168
Closed -$5K – 606
2016
Q4 		$5K Buy
+168
New +$5.32K ﹤0.01% 542

Other funds holding XLRN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $15.3B AUM 50.95% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return